PASG Passage Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 10, 2026
$4,12
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$3,29rendah 52m
$19,95tinggi 52m
Kapitalisasi Pasar (MRQ)
$13M
P/E
-0.3
EPS
$-14.35
lencana Anda
Rentang 52M
$3–$20
Peringkat Analis
BUY
Target Harga
$16
P/E
-0.3
ROE
-159.7%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
PASG Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.12
Kapitalisasi Pasar (MRQ)
$13M
P/E
-0.3
EPS
$-14.35
ROE
-159.7%
Rentang 52M
$3–$20
PASG Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 14 Juli 2025 | 1-for-20 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-14.352020-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | PASG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -0.3rata-rata 5T ≈-12.0 | ≈-12.0 | · | · | |
| P/B (MRQ) | 3.0rata-rata 5T ≈10.5 | ≈10.5 | 3.5 | Nilai wajar | |
| Price / Cash Flow (Harga / Arus Kas) | -0.4rata-rata 5T ≈-19.4 | ≈-19.4 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 0.7rata-rata 5T ≈10.5 | ≈10.5 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | PASG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -55.3%rata-rata 5T ≈-51.6% | ≈-51.6% | -89.9% | Tingkat teratas | |
| ROE | -159.7%rata-rata 5T ≈-92.1% | ≈-92.1% | -92.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | PASG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 1.2rata-rata 5T ≈7.0 | ≈7.0 | 3.1 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 2.0rata-rata 5T ≈2.3 | ≈2.3 | 2.0 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
3.2%
Laporan Berikutnya
Nov 09, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 10, 2026 | $-2.44 | $-2.70 | 9.6% |
| 31 Maret 2026 | Mei 11, 2026 | $-2.16 | $-2.85 | 24.1% |
| 31 Des. 2025 | $-3.95 | $-2.62 | -50.7% | |
| 30 Sep. 2025 | $-2.44 | $-2.86 | 14.6% | |
| 30 Juni 2025 | $-2.96 | $-4.13 | 28.3% | |
| 31 Maret 2025 | $-5.00 | $-4.69 | -6.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $23M | $40M | $61M | · | · | · | $3M | |
| SG&A Expense | $20M | $25M | $42M | $49M | $60M | $30M | $7M | |
| Operating Income | $-49M | $-70M | $-108M | $-138M | $-186M | $-113M | $-37M | |
| Interest Income | · | · | · | · | $343.0K | $670.0K | $696.0K | |
| Other Non-op | $4M | $6M | $6M | $2M | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | · | |
| Net Income | $-46M | $-65M | $-102M | $-136M | $-185M | $-112M | $-46M | |
| EPS (Basic) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | · | |
| EPS (Diluted) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | · | |
| Shares (Basic) | 3,172,870 | 3,078,665 | 54,743,490 | 54,429,023 | 53,343,959 | 38,615,967 | · | |
| Shares (Diluted) | 3,172,870 | 3,078,665 | 54,743,490 | 54,429,023 | 53,343,959 | 38,615,967 | · | |
| EBITDA | $-49M | $-67M | $-105M | $-135M | $-184M | $-112M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $38M | $22M | $35M | $129M | $135M | $159M | |
| Prepaid Expense | $629.0K | $838.0K | $923.0K | $926.0K | $2M | $1M | $156.0K | |
| Current Assets | $48M | $79M | $118M | $197M | $325M | $317M | $166M | |
| PP&E (Net) | $4M | $9M | $15M | $23M | $24M | $3M | $1M | |
| PP&E (Gross) | $8M | $19M | $23M | $28M | $26M | $4M | · | |
| Accum. Depreciation | $4M | $10M | $7M | $5M | $2M | $934.0K | · | |
| Other Non-current Assets | $244.0K | $463.0K | $433.0K | $4M | $6M | $8M | $12M | |
| Total Assets | $62M | $102M | $151M | $244M | $355M | $328M | $179M | |
| Accounts Payable | $1M | $742.0K | $1M | $4M | $9M | $5M | $629.0K | |
| Current Liabilities | $23M | $19M | $16M | $18M | $29M | $21M | $4M | |
| Capital Leases | $20M | $22M | $23M | $24M | · | · | · | |
| Deferred Tax | $3M | $4M | $6M | $8M | $1M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $41.0K | $76.0K | |
| Total Liabilities | $44M | $41M | $39M | $42M | $36M | $23M | $4M | |
| Common Stock | · | $6.0K | $5.0K | $5.0K | $5.0K | $4.0K | · | |
| Paid-in Capital | $724M | $720M | $706M | $695M | $675M | $476M | $2M | |
| Retained Earnings | $-705M | $-659M | $-594M | $-492M | $-356M | $-171M | $-59M | |
| AOCI | · | $8.0K | $-43.0K | $-966.0K | $-413.0K | $-12.0K | · | |
| Stockholders' Equity | $19M | $61M | $111M | $201M | $319M | $305M | $-56M | |
| Liabilities + Equity | $62M | $102M | $151M | $244M | $355M | $328M | $179M | |
| Shares Outstanding | 3,182,810 | 3,161,503 | 54,944,130 | 54,614,690 | 54,244,996 | 45,614,807 | 4,293,039 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $728.0K | $3M | $4M | $4M | $2M | $800.0K | $134.0K | |
| Stock-based Comp | $3M | $6M | $11M | $19M | $33M | $15M | $1M | |
| Other Non-cash | $10M | $8M | $9M | $-5M | $24M | $16M | · | |
| Operating Cash Flow | $-32M | $-48M | $-78M | $-118M | $-127M | $-81M | $-40M | |
| CapEx | · | $34.0K | · | · | · | · | · | |
| Investing Cash Flow | $40M | $55M | $65M | $25M | $-46M | $-172M | $-2M | |
| Stock Issued | · | · | · | · | $166M | $228M | · | |
| Net Stock Activity | · | · | · | · | $166M | $228M | · | |
| Financing Cash Flow | $23.0K | $9M | $135.0K | $-1M | $167M | $229M | $176M | |
| Net Change in Cash | $9M | $16M | $-13M | $-94M | $-6M | $-24M | $134M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -55.3% | -51.2% | -51.8% | -45.5% | -54.3% | -44.3% | · | |
| ROE | -159.7% | -96.7% | -85.9% | -63.9% | -54.4% | -34.9% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 4.1 | 7.2 | 10.7 | 11.0 | 15.0 | · | |
| Quick Ratio | 2.0 | 1.9 | 1.3 | 1.9 | 4.4 | 6.4 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.89 | $0.99 | $2.03 | $3.69 | $5.87 | $6.68 | · | |
| Cash Flow / Share | $-9.93 | $-0.79 | $-1.43 | $-2.17 | $-2.38 | · | · | |
| Cash / Share | $14.55 | $0.61 | $0.40 | $0.63 | $2.38 | $2.96 | · | |
| EPS (TTM) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-46M | $-65M | $-102M | $-136M | $-185M | $-112M | · | |
| Market Cap | $38M | $704M | $1.11B | $1.51B | $6.89B | $23.33B | · | |
| P/E | -0.8 | -0.5 | -10.9 | -11.0 | -36.5 | -175.7 | · | |
| P/B | 2.0 | 11.5 | 10.0 | 7.5 | 21.6 | 76.6 | · | |
| P / Tangible Book | 2.0 | 11.5 | 10.0 | 7.5 | 21.6 | 76.6 | · | |
| P / Cash Flow | -1.2 | -14.7 | -14.2 | -12.8 | -54.3 | -289.7 | · | |
| Earnings Yield | -121.6% | -185.5% | -9.2% | -9.1% | -2.7% | -0.57% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $4M | $5M | $4M | $6M | $8M | $10M | $9M | $10M | $12M | · | · | · | · | · | · | |
| SG&A Expense | $7M | $5M | $5M | $4M | $5M | $6M | $5M | $7M | $7M | $7M | $6M | $8M | $8M | $19M | $11M | $11M | |
| Operating Income | $-8M | $-8M | $-14M | $-9M | $-10M | $-16M | $-14M | $-21M | $-17M | $-18M | $-18M | $-29M | $-25M | $-36M | $-28M | $-28M | |
| Other Non-op | $451.0K | $688.0K | $865.0K | $906.0K | $949.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | · | · | |
| Net Income | $-8M | $-8M | $-13M | $-8M | $-9M | $-15M | $-13M | $-19M | $-16M | $-17M | $-17M | $-27M | $-24M | $-34M | $-27M | $-27M | |
| EPS (Basic) | $-2.44 | $-2.36 | $-8.70 | $-2.44 | $-2.96 | $-4.87 | $-9.50 | $-6.15 | $-5.09 | $-0.30 | $-0.30 | $-0.49 | $-0.44 | $-0.63 | $-0.49 | $-0.49 | |
| EPS (Diluted) | $-2.44 | $-2.36 | $-8.70 | $-2.44 | $-2.96 | $-4.87 | $-9.50 | $-6.15 | $-5.09 | $-0.30 | $-0.30 | $-0.49 | $-0.44 | $-0.63 | $-0.49 | $-0.49 | |
| Shares (Basic) | 3,208,744 | 3,205,866 | · | 3,178,710 | 3,168,933 | 3,163,914 | · | 3,146,582 | 3,142,537 | 56,295,540 | · | 54,789,410 | 54,683,817 | 54,618,799 | · | 54,473,945 | |
| Shares (Diluted) | 3,208,744 | 3,205,866 | · | 3,178,710 | 3,168,933 | 3,163,914 | · | 3,146,582 | 3,142,537 | 56,295,540 | · | 54,789,410 | 54,683,817 | 54,618,799 | · | 54,473,945 | |
| EBITDA | $-8M | $-8M | · | $-8M | $-10M | $-16M | · | $-20M | $-17M | $-17M | · | $-28M | $-24M | $-35M | · | $-28M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24M | $33M | $46M | $53M | $58M | $63M | $38M | $32M | $25M | $37M | $22M | $34M | $30M | $33M | $35M | $63M | |
| Prepaid Expense | $768.0K | $682.0K | $629.0K | $2M | $1M | $2M | $838.0K | $1M | $1M | $2M | $923.0K | $1M | $1M | $2M | $926.0K | $2M | |
| Current Assets | $25M | $35M | $48M | $56M | $60M | $67M | $79M | $87M | $95M | $108M | $118M | $136M | $154M | $172M | $197M | $223M | |
| PP&E (Net) | · | $826.0K | $4M | $5M | $5M | $6M | $9M | $10M | $13M | $14M | $15M | $16M | $20M | $22M | $23M | $23M | |
| PP&E (Gross) | · | $3M | $8M | $9M | $9M | $9M | $19M | $19M | $22M | $23M | $23M | $22M | $27M | $28M | $28M | $27M | |
| Accum. Depreciation | · | $2M | $4M | $4M | $4M | $3M | $10M | $9M | $9M | $8M | $7M | $6M | $7M | $6M | $5M | $4M | |
| Other Non-current Assets | · | $244.0K | $244.0K | $270.0K | $270.0K | $274.0K | $463.0K | $463.0K | $516.0K | $662.0K | $433.0K | $433.0K | $433.0K | $433.0K | $4M | $5M | |
| Total Assets | $25M | $36M | $62M | $74M | $79M | $86M | $102M | $112M | $125M | $141M | $151M | $169M | $194M | $213M | $244M | $270M | |
| Accounts Payable | $902.0K | $1M | $1M | $952.0K | $2M | $1M | $742.0K | $1M | $621.0K | $2M | $1M | $3M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $21M | $20M | $23M | $22M | $20M | $18M | $19M | $17M | $12M | $13M | $16M | $20M | $20M | $17M | $18M | $22M | |
| Capital Leases | · | $5M | $20M | $21M | $21M | $21M | $22M | $22M | $22M | $23M | $23M | $23M | $23M | $24M | $24M | $24M | |
| Deferred Tax | · | · | $3M | · | · | · | $4M | · | · | · | $6M | · | · | · | $8M | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | |
| Total Liabilities | $21M | $25M | $44M | $43M | $41M | $39M | $41M | $39M | $35M | $36M | $39M | $43M | $43M | $43M | $42M | $46M | |
| Common Stock | · | · | · | · | · | $6.0K | · | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $725M | $724M | $724M | $723M | $722M | $721M | $720M | $719M | $718M | $716M | $706M | $704M | $701M | $698M | $695M | $691M | |
| Retained Earnings | $-720M | $-712M | $-705M | $-692M | $-684M | $-675M | $-659M | $-647M | $-627M | $-611M | $-594M | $-578M | $-551M | $-527M | $-492M | $-465M | |
| AOCI | · | · | · | · | · | · | $8.0K | $32.0K | $-67.0K | $-69.0K | $-43.0K | $-192.0K | $-340.0K | $-427.0K | $-966.0K | $-1M | |
| Stockholders' Equity | $4M | $12M | $19M | $31M | $38M | $47M | $61M | $73M | $91M | $105M | $111M | $126M | $150M | $170M | $201M | $224M | |
| Liabilities + Equity | $25M | $36M | $62M | $74M | $79M | $86M | $102M | $112M | $125M | $141M | $151M | $169M | $194M | $213M | $244M | $270M | |
| Shares Outstanding | 3,217,810 | 3,207,810 | 3,182,810 | 3,178,710 | 3,178,710 | 62,148,274 | 3,161,503 | 61,767,286 | 61,754,786 | 61,611,796 | 54,944,130 | 54,812,972 | 54,745,680 | 54,626,690 | 54,614,690 | 54,546,596 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $25.0K | $129.0K | $127.0K | $200.0K | $200.0K | $201.0K | $675.0K | $800.0K | $800.0K | $806.0K | $743.0K | $1M | $1M | $978.0K | $996.0K | $900.0K | |
| Stock-based Comp | $525.0K | $556.0K | $609.0K | $611.0K | $923.0K | $858.0K | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $3M | $3M | $3M | |
| Other Non-cash | · | $-6M | · | · | · | $499.0K | · | · | · | $-5M | · | · | · | $8M | · | · | |
| Operating Cash Flow | $-9M | $-13M | $-6M | $-5M | $-6M | $-14M | $-8M | $-7M | $-13M | $-19M | $-20M | $-19M | $-17M | $-22M | $-24M | $-23M | |
| Investing Cash Flow | $0 | $20.0K | $0 | $0 | $585.0K | $40M | $14M | $15M | $1M | $25M | $8M | $22M | $14M | $21M | $-3M | $-5M | |
| Financing Cash Flow | · | · | $9.0K | $0 | · | · | $47.0K | $0 | $85.0K | $9M | $46.0K | $0 | · | · | $-588.0K | $-408.0K | |
| Net Change in Cash | $-9M | $-13M | $-6M | $-5M | $-6M | $26M | $5M | $8M | $-12M | $15M | $-12M | $3M | $-3M | $-1M | $-28M | $-29M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -12.3% | · | -8.3% | -9.2% | -13.6% | · | -13.8% | -10.0% | -9.4% | · | -12.3% | -9.7% | -12.6% | · | -8.1% | |
| ROE | -36.6% | -25.9% | · | -14.9% | -14.6% | -20.3% | · | -19.4% | -13.3% | -12.1% | · | -15.5% | -12.0% | -15.2% | · | -9.1% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.7 | · | 2.5 | 3.0 | 3.7 | · | 5.1 | 7.7 | 8.4 | · | 6.9 | 7.7 | 10.0 | · | 10.3 | |
| Quick Ratio | 1.2 | 1.7 | · | 2.4 | 2.9 | 3.6 | · | 1.9 | 2.0 | 2.9 | · | 1.7 | 1.5 | 1.9 | · | 2.9 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.38 | $3.66 | · | $9.79 | $12.04 | $0.75 | · | $1.18 | $1.47 | $1.70 | · | $2.30 | $2.75 | $3.12 | · | $4.11 | |
| Cash Flow / Share | · | $-4.05 | · | · | · | $-0.22 | · | · | · | $-0.34 | · | · | · | $-0.41 | · | · | |
| Cash / Share | $7.51 | $10.39 | · | $16.60 | $18.13 | $1.02 | · | $0.52 | $0.40 | $0.60 | · | $0.61 | $0.55 | $0.61 | · | $1.15 | |
| EPS (TTM) | $-15.94 | $-16.46 | · | $-19.77 | $-23.48 | $-25.61 | · | $-11.84 | $-6.18 | $-1.53 | · | $-2.05 | $-2.05 | $-2.34 | · | $-2.96 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-36M | $-38M | · | $-45M | $-57M | $-63M | · | $-69M | $-77M | $-84M | · | $-112M | $-112M | $-128M | · | $-160M | |
| Market Cap | $16M | $25M | · | $26M | $25M | $439M | · | $865M | $981M | $1.66B | · | $721M | $1.03B | $1.05B | · | $1.36B | |
| P/E | -0.3 | -0.5 | · | -0.4 | -0.3 | -0.3 | · | -1.2 | -2.6 | -17.6 | · | -6.4 | -9.2 | -8.2 | · | -8.4 | |
| P/B | 3.5 | 2.1 | · | 0.8 | 0.7 | 9.4 | · | 11.9 | 10.8 | 15.9 | · | 5.7 | 6.8 | 6.1 | · | 6.1 | |
| P / Tangible Book | 3.5 | 2.1 | · | 0.8 | 0.7 | 9.4 | · | 11.9 | 10.8 | 15.9 | · | 5.7 | 6.8 | 6.1 | · | 6.1 | |
| P / Cash Flow | · | -1.9 | · | · | · | -31.7 | · | · | · | -87.9 | · | · | · | -46.6 | · | · | |
| Earnings Yield | -326.6% | -209.7% | · | -246.2% | -293.5% | -362.8% | · | -84.6% | -38.9% | -5.7% | · | -15.6% | -10.9% | -12.2% | · | -11.8% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-46M | $-65M | $-102M | $-136M | $-185M |
| EPS Dilusian | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 2.1 | 4.1 | 7.2 | 10.7 | 11.0 |
| Rasio Cepat | 2.0 | 1.9 | 1.3 | 1.9 | 4.4 |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 32 pengaju · $8.8M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
32
Nilai yang dipegang
$8.8M
Posisi baru
4
Posisi yang keluar
9
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 4 (-8 vs Kuartal sebelumnya) | 9 (+3 vs Kuartal sebelumnya) | 5 (-1 vs Kuartal sebelumnya) | 7 (+3 vs Kuartal sebelumnya) | -382K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $3.287.942 | 673.759 | 37,17% | Saham |
| VANGUARD GROUP INC | $1.494.411 | 126.645 | 16,89% | Saham |
| New Leaf Venture Partners, L.L.C. | $702.031 | 87.426 | 7,94% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $556.144 | 113.964 | 6,29% | Saham |
| Balyasny Asset Management L.P. | $522.282 | 107.025 | 5,90% | Saham |
| Ikarian Capital, LLC | $485.643 | 99.517 | 5,49% | Saham |
| Yiheng Capital Management, L.P. | $420.153 | 86.097 | 4,75% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $233.713 | 47.892 | 2,64% | Saham |
| Erste Asset Management GmbH | $197.225 | 40.665 | 2,23% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $180.716 | 37.026 | 2,04% | Saham |
| Verdad Advisers, LP | $149.953 | 30.728 | 1,70% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $138.782 | 28.439 | 1,57% | Saham |
| BlackRock, Inc. | $136.201 | 27.910 | 1,54% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $83.199 | 17.049 | 0,94% | Saham |
| DELTEC ASSET MANAGEMENT LLC | $73.200 | 15.000 | 0,83% | Saham |
| UBS Group AG | $66.197 | 13.565 | 0,75% | Saham |
| Fiduciary Trust Co | $52.460 | 10.750 | 0,59% | Saham |
| GTS SECURITIES LLC | $48.800 | 10.000 | 0,55% | Saham |
| MORGAN STANLEY | $11.658 | 2.389 | 0,13% | Saham |
| Vanguard Global Advisers, LLC | $3.113 | 638 | 0,04% | Saham |
| BARCLAYS PLC | $1.035 | 212 | 0,01% | Saham |
| SBI Securities Co., Ltd. | $825 | 169 | 0,01% | Saham |
| WELLS FARGO & COMPANY/MN | $561 | 115 | 0,01% | Saham |
| ACADIAN ASSET MANAGEMENT LLC | $109 | 22.496 | 0,00% | Saham |
| JPMORGAN CHASE & CO | $73 | 15 | 0,00% | Saham |
| OSAIC HOLDINGS, INC. | $73 | 15 | 0,00% | Saham |
| HRT FINANCIAL LP | $62 | 12.712 | 0,00% | Saham |
| LRI Investments, LLC | $59 | 12 | 0,00% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $59 | 12 | 0,00% | Saham |
| HARBOUR INVESTMENTS, INC. | $15 | 3 | 0,00% | Saham |
| CWM, LLC | $8 | 1 | 0,00% | Saham |
| TSFG, LLC | $0 | 5 | 0,00% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP, Weston Nichols | 2 Juli 2026 | 21,00% | Pengajuan awal | M&A / penjualan | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC ×10 pengajuan | 24 Juli 2025 | 4,25% | Amandemen | · | SEC |
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC ×4 pengajuan | 9 Agu 2024 | · | Pengajuan awal | · | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., James N. Topper, Patrick J. Heron ×4 pengajuan | 15 Juni 2023 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 25 orang dalam · 13 pejabat · 11 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| William Chou | PRESIDENT AND CEO | 16 Maret 2026 A | 6.524 | 0 | 1 | $-75.161 |
| Bruce A Goldsmith | CEO and President | 27 Mei 2022 A | 15.983 | 0 | 0 | $0 |
| Kathleen Borthwick | CFO | 16 Maret 2026 A | 5.402 | 0 | 1 | $-38.023 |
| Simona King | Chief Financial Officer | 28 Juli 2023 M | 23.994 | 0 | 0 | $0 |
| Richard Steven Morris | Chief Financial Officer | 21 Mei 2021 P | 5.454 | 0 | 0 | $0 |
| Jill M. Quigley | Chief Operating Officer | 8 Des. 2021 M | 368.754 | 0 | 0 | $0 |
| Edgar B. Cale | GC & CORPORATE SECRETARY | 15 Maret 2025 A | 45.995 | 0 | 0 | $0 |
| Mark S Forman | CHIEF MEDICAL OFFICER | 15 Maret 2024 A | 48.631 | 0 | 0 | $0 |
| Alexandros Fotopoulos | Chief Technical Officer | 15 Juni 2023 M | 28.693 | 0 | 0 | $0 |
| Monika Maria Toernsen | Chief Commercial Officer | 15 Sep. 2022 M | 3.319 | 0 | 0 | $0 |
| Eliseo Oreste Salinas | Chief Res. & Develop Officer | 10 Feb. 2022 A | · | 0 | 0 | $0 |
| Gary Romano | Chief Medical Officer | 15 Maret 2021 M | 0 | 0 | 0 | $0 |
| Stephen P Squinto | Head of Research and Dev | 27 Feb. 2020 A | · | 0 | 0 | $0 |
| Dolan Sondhi | Direktur | 19 Mei 2026 A | · | 0 | 0 | $0 |
| Derrell Porter | Direktur | 19 Mei 2026 A | · | 0 | 0 | $0 |
| Sandip Kapadia | Direktur | 19 Mei 2026 A | 0 | 0 | 0 | $0 |
| Athena Countouriotis | Direktur | 19 Mei 2026 A | 18.900 | 0 | 0 | $0 |
| Saqib Islam | Direktur | 28 Mei 2025 A | 5.000 | 0 | 0 | $0 |
| Thomas Woiwode | Direktur | 25 Mei 2023 A | 933.352 | 0 | 0 | $0 |
| Michael E. Kamarck | Direktur | 25 Mei 2023 A | · | 0 | 0 | $0 |
| Patrick J. Heron | Direktur | 3 Maret 2020 C | 5.009.219 | 0 | 0 | $0 |
| Thomas Richard Kassberg | · | 19 Mei 2026 A | · | 0 | 0 | $0 |
| Maxine Gowen | · | 19 Mei 2026 A | · | 0 | 0 | $0 |
| Liam Ratcliffe | · | 27 Mei 2021 A | 2.800 | 0 | 0 | $0 |
| Tadataka Yamada | · | 27 Mei 2021 A | 656.149 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 3 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
PASG Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 9 analis
BELI
Target median
$15.50
+276,2%
2 22,2%
Beli Kuat
4 44,4%
Beli
3 33,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
2 analis · 2026-10-02Target rata-rata $15.50 +276,2%
← Di bawah semua target
Harga saat ini $4.12
Rendah$8.00
Rata-rata$15.50
Tinggi$23.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 10, 2026